Debt-to-equity in % of Bionik Laboratories Corp. from Q2 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bionik Laboratories Corp. quarterly Debt-to-equity history and change rate from Q2 2012 to Q1 2023.
  • Bionik Laboratories Corp. Debt-to-equity for the quarter ending 31 Mar 2023 was -348 %, a 4744% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Bionik Laboratories Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2023 -348 -356 -47.4% 31 Mar 2023
Q4 2022 2 -5 -66.8% 31 Dec 2022
Q3 2022 29 +27 +9.2% 30 Sep 2022
Q2 2022 10 30 Jun 2022
Q1 2022 7 31 Mar 2022
Q4 2021 7 31 Dec 2021
Q3 2021 2 30 Sep 2021
Q1 2017 0 -8 -97.3% 31 Mar 2017
Q4 2016 0 -7 -96.8% 31 Dec 2016
Q3 2016 0 -8 -95.5% 30 Sep 2016
Q2 2016 0 -3 -78.6% 30 Jun 2016
Q1 2016 8 31 Mar 2016
Q4 2015 7 31 Dec 2015
Q3 2015 7 30 Sep 2015
Q2 2015 3 30 Jun 2015
Q2 2012 0* 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.